ZG-126
Product Specifications
UNSPSC Description
ZG-126 is an agonist for vitamin D receptor (VDR) and an inhibitor for histone deacetylase (HDAC) (IC50=0.63-67.6 μM). ZG-126 exhibits cytotoxicity in cancer cells MDA-MB-231 and 4T1. ZG-126 exhibits antitumor and anti-metastatic efficacy against melanoma and triple-negative breast cancer (TNBC) in mouse models. ZG-126 also exhibits anti-inflammatory activity, through the reduction of macrophage infiltration and immunosuppressive M2-polarization[1].
Target Antigen
HDAC; VD/VDR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage;Epigenetics;Vitamin D Related/Nuclear Receptor
Applications
COVID-19-anti-virus
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/zg-126.html
Smiles
CCC(CC)(C1=CC=C(C=C1)C(NCCCCC(NO)=O)=O)C2=NC(C)=C(C=C2)OCC(C(C)(C)C)O
Molecular Weight
513.67
References & Citations
[1]Sarmadi F, et al., Bifunctionality and Antitumor Efficacy of ZG-126, a Vitamin D Receptor Agonist/Histone Deacetylase Inhibitor Hybrid Molecule. J Med Chem. 2024 Jun 21.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-161778/ZG-126-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-161778/
Clinical Information
No Development Reported
CAS Number
3049802-32-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS7169005 Inquire
Rabbit anti-Escherichia coli O9:H4 (strain HS) SSUD Polyclonal Antibody
Ask
View Details 